Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatobiliary neoplasms
ADR ID BADD_A02039
ADR Hierarchy
09      Hepatobiliary disorders
09.04      Hepatobiliary neoplasms
Description Not Available
MedDRA Code 10019811
MeSH ID Not Available
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib--
BADD_D02246Tolvaptan--
BADD_D02257Trametinib--
BADD_D02312Ulipristal--
BADD_D02331Valsartan--
BADD_D02334Vandetanib--
BADD_D02342Vedolizumab--
BADD_D02344Vemurafenib--
BADD_D02345Venetoclax--
BADD_D02369Voriconazole--
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02393Zolmitriptan--
BADD_D02407Upadacitinib--
BADD_D02412Octreotide--
BADD_D02436Atorvastatin--
BADD_D02452Icatibant--
BADD_D02464Fingolimod--
BADD_D02469Edoxaban--
BADD_D02470Nintedanib--
BADD_D02480Alectinib--
BADD_D02483Ribociclib--
BADD_D02490Apalutamide--
BADD_D02498Abemaciclib--
BADD_D02500Alpelisib--
BADD_D02503Telotristat ethyl--
BADD_D02509Brigatinib--
BADD_D02510Rucaparib--
BADD_D02517Enasidenib--
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages